LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 31.55 | 771.67 | 3200 | 3196 | 1.0010 | 1.0010 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 31.55 | 771.67 | 3680 | 3196 | 1.1512 | 1.1421 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 33.78 | 771.67 | 3502 | 3499 | 1.0007 | 1.0006 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 33.78 | 771.67 | 3895 | 3499 | 1.1130 | 1.1006 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 36.00 | 771.67 | 3823 | 3884 | 0.9841 | 0.9863 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 36.00 | 771.67 | 4279 | 3884 | 1.1015 | 1.0847 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 38.22 | 771.67 | 4271 | 4299 | 0.9933 | 0.9946 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 38.22 | 771.67 | 4741 | 4299 | 1.1027 | 1.0804 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 40.44 | 771.67 | 4669 | 4738 | 0.9854 | 0.9888 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 40.44 | 771.67 | 5287 | 4738 | 1.1158 | 1.0855 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 42.67 | 771.67 | 5039 | 5155 | 0.9774 | 0.9834 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 42.67 | 771.67 | 5640 | 5155 | 1.0939 | 1.0666 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 44.89 | 771.67 | 5476 | 5541 | 0.9882 | 0.9917 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 44.89 | 771.67 | 6193 | 5541 | 1.1176 | 1.0797 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 47.11 | 771.67 | 5896 | 5941 | 0.9923 | 0.9948 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 47.11 | 771.67 | 6530 | 5941 | 1.0990 | 1.0652 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 49.33 | 771.67 | 6400 | 6392 | 1.0012 | 1.0008 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 49.33 | 771.67 | 6979 | 6392 | 1.0917 | 1.0584 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 51.55 | 771.67 | 7027 | 6829 | 1.0289 | 1.0182 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 51.55 | 771.67 | 7542 | 6829 | 1.1043 | 1.0641 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 53.77 | 771.67 | 7477 | 7256 | 1.0304 | 1.0186 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 53.77 | 771.67 | 8105 | 7256 | 1.1169 | 1.0696 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 55.99 | 771.67 | 7874 | 7690 | 1.0239 | 1.0143 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 55.99 | 771.67 | 8507 | 7690 | 1.1062 | 1.0618 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.21 | 771.67 | 8338 | 8085 | 1.0312 | 1.0182 | MN20160304_L01 | L18 |